ConductScience.org, home

Paper38412036

A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.

Joshi VR and 11 others. J Virol, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope. Papers, record 38412036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38412036

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
PubMed
Journal
J Virol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2026-03-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Joshi VRVinita Rhttps://orcid.org/0000-0002-3032-137X
2Claiborne DTDaniel Thttps://orcid.org/0000-0002-2091-1456
3Pack MLMelissa L
4Power KAKaren A
5Newman RMRuchi M
6Batorsky RRebecca
7Bean DJDavid J
8Goroff MSMatthew S
9Lingwood DDaniel
10Seaman MSMichael S
11Rosenberg EEric
12Allen TMTodd Mhttps://orcid.org/0000-0002-6609-1318

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Broadly Neutralizing AntibodiesMajor topic
HIV InfectionsMajor topic
Humans
Amino Acids
CD4 Antigens
env Gene Products, Human Immunodeficiency Virus
Epitopes
HIV Antibodies
HIV Antigens
HIV Envelope Protein gp120
HIV Seropositivity
HIV-1
AIDS Vaccines

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI137057NIAID NIH HHSUnited StatesR01AI137057PubMedNIH RePORTER
R01 AI153098NIAID NIH HHSUnited StatesR01AI153098PubMedNIH RePORTER
R01 AI155447NIAID NIH HHSUnited StatesR01AI155447PubMedNIH RePORTER
AI04715HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)PubMedPubMed
P01 AI104715NIAID NIH HHSUnited StatesP01AI104715PubMedNIH RePORTER

Download CSV of grants

References104

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123539181Rational HIV immunogen design to target specific germline B cell receptors.Science2013https://conductscience.org/library/papers/23539181PubMed
226091035Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice.Cell2015https://conductscience.org/library/papers/26091035PubMed
326949186Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.Cell2016https://conductscience.org/library/papers/26949186PubMed
426702094Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.Sci Transl Med2015https://conductscience.org/library/papers/26702094PubMed
520439465Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.J Biol Chem2010https://conductscience.org/library/papers/20439465PubMed
67973652Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.Science1994https://conductscience.org/library/papers/7973652PubMed
727013733HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.Science2016https://conductscience.org/library/papers/27013733PubMed
830936546Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.Nat Med2019https://conductscience.org/library/papers/30936546PubMed
923524883Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23524883PubMed
1027192579Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.Immunity2016https://conductscience.org/library/papers/27192579PubMed
1133878161Cell engineering for the production of hybrid-type N-glycans in HEK293 cells.J Biochem2021https://conductscience.org/library/papers/33878161PubMed
1212644702Rapid evolution of the neutralizing antibody response to HIV type 1 infection.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12644702PubMed
1312719580Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.J Virol2003https://conductscience.org/library/papers/12719580PubMed
1430326938The expanding array of HIV broadly neutralizing antibodies.Retrovirology2018https://conductscience.org/library/papers/30326938PubMed
1532004464Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.Cell2020https://conductscience.org/library/papers/32004464PubMed
1620679402Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness.J Exp Med2010https://conductscience.org/library/papers/20679402PubMed
1725855300Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.Nature2015https://conductscience.org/library/papers/25855300PubMed
1829718999Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.PLoS Pathog2018https://conductscience.org/library/papers/29718999PubMed
1927338952HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.Nature2016https://conductscience.org/library/papers/27338952PubMed
2012019106Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12019106PubMed

See all 104 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42774884Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies.iScience2026https://conductscience.org/library/papers/42774884

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38412036

GET https://conductscience.org/api/papers/v1/38412036/references?page=2